Skip to main content
. 2015 Oct 16;21(6):10.18553/jmcp.2015.21.6.452. doi: 10.18553/jmcp.2015.21.6.452
Coefficient Standard Error 95% CI P Value
Total charges
  DCCM in the post-index period (interaction term) -0.423 0.176 -0.768 -0.079 0.016
  DCCM group assignment (reference comparison) 0.803 0.138 0.533 1.073 < 0.001
  Post-index period (reference pre-index period) 0.441 0.116 0.214 0.668 < 0.001
  Baseline HbA1c -0.107 0.025 -0.156 -0.059 < 0.001
  Age 0.009 0.003 0.002 0.016 0.012
  Pre-index diabetes medications
    Metformin 0.161 0.135 -0.103 0.424 0.233
    Insulin use 0.304 0.112 0.084 0.523 0.007
  Pre-index diabetes medications by number of classes (reference 2-3)
    0-1 -0.222 0.128 -0.472 0.029 0.082
    4+ -0.118 0.137 -0.386 0.151 0.390
  Comorbidities
    Retinopathy 0.521 0.184 0.160 0.883 0.005
    Chronic kidney disease 0.541 0.135 0.277 0.805 < 0.001
  Black race (reference white) -0.071 0.339 -0.737 0.594 0.834
  Male (reference female) -0.273 0.088 -0.446 -0.100 0.002
  Constant 7.100 0.378 6.359 7.841 < 0.001
Inpatient charges
  DCCM in the post-index period (interaction term) -0.142 0.237 -0.608 0.324 0.550
  DCCM group assignment (reference comparison) 0.436 0.186 0.071 0.801 0.019
  Post-index period (reference pre-index period) 0.061 0.157 -0.246 0.368 0.697
  Baseline HbA1c 0.022 0.033 -0.044 0.087 0.511
  Age 0.001 0.005 -0.008 0.010 0.862
  Pre-index diabetes medications
    Metformin 0.082 0.182 -0.275 0.438 0.653
    Insulin use 0.204 0.151 -0.093 0.500 0.178
  Pre-index diabetes medications by number of classes (reference 2-3)
    0-1 0.163 0.172 -0.175 0.501 0.345
    4+ 0.238 0.185 -0.125 0.600 0.198
  Comorbidities
    Retinopathy 0.196 0.249 -0.292 0.683 0.432
    Chronic kidney disease 0.537 0.182 0.181 0.894 0.003
  Black race (reference white) -0.728 0.458 -1.627 0.171 0.113
  Male (reference female) 0.109 0.119 -0.125 0.342 0.363
  Constant -0.268 0.510 -1.269 0.733 0.599
Outpatient charges
  DCCM in the post-index period (interaction term) -0.419 0.167 -0.747 -0.092 0.012
  DCCM group assignment (reference comparison) 0.750 0.131 0.493 1.007 < 0.001
  Post-index period (reference pre-index period) 0.474 0.110 0.258 0.690 < 0.001
  Baseline HbA1c -0.115 0.023 -0.161 -0.069 < 0.001
  Age 0.008 0.003 0.002 0.015 0.013
  Pre-index diabetes medications
    Metformin 0.161 0.128 -0.089 0.412 0.207
    Insulin use 0.253 0.106 0.045 0.461 0.017
  Pre-index diabetes medications by number of classes (reference 2-3)
    0-1 -0.251 0.121 -0.489 -0.014 0.038
    4+ -0.120 0.130 -0.375 0.135 0.355
  Comorbidities
    Retinopathy 0.561 0.175 0.218 0.904 0.001
    Chronic kidney disease 0.493 0.128 0.242 0.743 < 0.001
  Black race (reference white) 0.051 0.322 -0.581 0.683 0.875
  Male (reference female) -0.294 0.084 -0.459 -0.130 < 0.001
  Constant 7.171 0.359 6.468 7.875 < 0.001

CI = confidence interval; DCCM = diabetes collaborative care management; HbA1c = hemoglobin A1c.